研究概要
克服缺氧肿瘤微环境(TME)和免疫抑制仍然是实体膀胱肿瘤治疗中的重大挑战。
中文摘要
克服缺氧肿瘤微环境(TME)和免疫抑制仍然是实体膀胱肿瘤治疗中的重大挑战。本研究引入了一种纳米编排的类趋磁系统的转化体系,整合光合氧合、远程热疗和铁死亡,以实现全面的肿瘤根除和免疫激活。所开发的系统由电磁响应性氧化铁纳米颗粒(IO NPs)封装在乙二醇壳聚糖(GCS)基质中并包覆于小球藻(CHL;CHL-GCS-IO NPs)上组成,展现出用于精确磁靶向、光热-热疗和光照下光合驱动产氧的多功能性。CHL通过持续缓解缺氧增强产氧,提升了电磁治疗疗效和铁死亡诱导的肿瘤细胞死亡。此外,多模式CHL-GCS-IO NPs重编程了TME,通过促进巨噬细胞向促炎M1表型极化、招募细胞毒性T细胞和NK 细胞、程序性死亡配体1(PD-L1)下调以及驱动树突状细胞重编程以改善抗原呈递,从而促进免疫激活。在体内,该方法在膀胱癌模型中显示出显著的肿瘤生长抑制并防止复发,凸显了其实现强效且持久抗癌免疫的潜力。这种类趋磁CHL平台提出了一种极具前景的诊疗一体化策略,将多模式治疗与免疫调节相结合,以应对实体膀胱肿瘤的直接和系统性挑战。
展开英文摘要原文
Overcoming the hypoxic tumor microenvironment (TME) and immune suppression remains a significant challenge in solid bladder tumor therapies. This study introduces a translational system of nano-orchestrated magnetotactic-like system, integrating photosynthetic oxygenation, remote hyperthermia, and ferroptosis to achieve comprehensive tumor eradication and immune activation. The developed system, composed of electromagnetic-responsive iron oxide nanoparticles (IO NPs) encapsulated within a glycol chitosan (GCS) matrix and coated onto Chlorella (CHL; CHL-GCS-IO NPs), exhibited versatility for precise magnetic targeting, photothermal-hypertehrmia and photosynthesis-driven oxygen generation under light irradiation. The CHL enhanced oxygen production by continuously alleviating hypoxia, boosting both electromagnetic therapeutic efficacies and ferroptosis-induced tumor cell death. Moreover, the multimodal CHL-GCS-IO NPs reprogrammed the TME, facilitating immune activation by promoting macrophage polarization towards the proinflammatory M1 phenotype, engaging cytotoxic T cells and natural killer cells, programmed death ligand 1 (PD-L1) downregulation, and driving dendritic cell reprogramming towards improved antigen presentation. In vivo, this approachsuggested significant tumor growth inhibition and prevented recurrence in bladder cancer models, highlighting its potential for robust and durable anticancer immunity. This magnetotactic-like CHL platform presents a highly promising theranostic strategy, merging multimodal therapies with immune modulation to tackle both direct and systemic challenges of solid bladder tumors.
论文信息
- 作者
- Hsiao CH、Lin YW、Liu CH、Chen YT、Nguyen HT、Chuang AE
- 第一作者单位
- Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, New Taipei City, 235603, Taiwan.Taiwan
- 通讯作者单位
- Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, New Taipei City, 235603, Taiwan. eychuang@tmu.edu.tw.Taiwan
- 期刊
- Journal of nanobiotechnology2025 Jun 13